Battle of the Biomarkers of Systemic Inflammation
Biology · 18.04.2025 · 14 (4) · 438
DOI: 10.3390/biology14040438 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 18.04.2025. Verfasst von Emilia Stec-Martyna und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Laboratory CoreLab, Medical University of Lodz, 6/8 Mazowiecka St., 92-215 Lodz, Poland. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University Lodz.
Abstract (Originalsprache)
Systemic inflammation is monitored with various biomarkers; of these, C-reactive protein (CRP) is widely used due to its cost effectiveness and widespread implementation. However, its lack of specificity and delayed kinetics have directed interest in cell-free DNA (cfDNA), which offers rapid responses to cellular damage. Our review compares the use of CRP and cfDNA in myocardial infarction, sepsis, and physical exercise, focusing on their origins, kinetics, and clinical utility. cfDNA release from apoptotic or damaged cells increases within minutes to hours, providing an early marker of cellular stress. In myocardial infarction, cfDNA peaks early, indicating acute injury, while CRP rises later, reflecting prolonged inflammation. In sepsis, cfDNA correlates strongly with disease severity and prognosis, outperforming CRP in early diagnosis. During physical exercise, cfDNA offers an immediate picture of cellular stress, whereas CRP’s delayed response limits its utility in this context. The interaction between CRP and cfDNA suggests their combined application could improve diagnostic accuracy and prognostic assessments. As cfDNA testing becomes more widely available, researchers will need to develop standardized protocols and determine how it can best complement CRP measurements in clinical practice. This approach offers promise for improving the management of systemic inflammation across diverse medical conditions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Laboratory CoreLab, Medical University of Lodz, 6/8 Mazowiecka St., 92-215 Lodz, Poland.
- Department of Clinical Physiology, Medical University of Lodz, 92-215 Lodz, Poland.
ORCID-Profile: Emilia Stec-Martyna, Dariusz Nowak, Robert Stawski
Förderung
- Medical University Lodz
Zitieren
APA
Stec-Martyna, E., Wojtczak, K., Nowak, D., & Stawski, R. (2025). Battle of the Biomarkers of Systemic Inflammation. Biology, 14(4), 438. https://doi.org/10.3390/biology14040438
Vancouver
Stec-Martyna E, Wojtczak K, Nowak D, Stawski R. Battle of the Biomarkers of Systemic Inflammation. Biology. 2025;14(4):438. doi:10.3390/biology14040438
BibTeX
@article{StecMartyna2025,
author = {Stec-Martyna, Emilia and Wojtczak, Karolina and Nowak, Dariusz and Stawski, Robert},
title = {Battle of the Biomarkers of Systemic Inflammation},
journal = {Biology},
year = {2025},
volume = {14},
number = {4},
pages = {438},
doi = {10.3390/biology14040438}
}
EUVIMED